Estimated annual percentage change in age-standardized prevalence rates of gynecological diseases across 204 countries and territories in 2021. by Xiaofeng He (2618752)

Estimated annual percentage changes in the prevalence rate of specific gynecological diseases from 1990 to 2021, categorized by age group and SDI. by Xiaofeng He (2618752)

Prevalence and trends of gynecological diseases (GDs) among women of childbearing age, by age group and SDI. by Xiaofeng He (2618752)

Prevalence of gynecological diseases (GDs) among women of childbearing age in 2021, along with their changes from 1990 to 2021, and the contribution of each GD to the overall preva... by Xiaofeng He (2618752)

A) Expression of known ‘tendon’ transcription factors, B) TGFβ and C) ECM genes measured with RNA-seq. by Heather L. Dingwall (14573796)

“…Expression of ECM related genes are significantly differentially expressed in unique directions during postnatal stages with <i>Dcn</i> and <i>Fmod</i> increasing gradually over time, <i>Col2a1</i>, <i>Col14a1</i>, <i>Col3a1</i>, and <i>Tnmd</i> decreasing over time, <i>Col1a1</i> and <i>Col1a2</i> peak in expression at P14, and <i>Bgn</i> is expressed at higher levels from P0-P14 after which its levels decrease (C). …”

Neonatal deletion of Yap in Scx-lineage cells disrupts collagen production in the tendon during postnatal development. by Heather L. Dingwall (14573796)

“…<b>E)</b> RT-qPCR shows decreased expression of Col1a2, Ki67, and Yap in and Yap-cKO tendon at P14 compared to controls. …”

Lesioning silent neurons reveals functional role. by Thomas S. Wierda (22404198)

“…<p><b>a</b> We lesioned neurons that were silent by forcing their firing rate to be zero at every timestep. …”

PPI network analysis. by Du Leng (20421711)

ELISA of the key proteins. by Du Leng (20421711)

“…KEGG pathway analysis showed a significant enrichment of DEPs in PI3K-Akt pathway and focal adhesion. …”

S1 Data - by George Mrema (19550255)

“…Additionally, despite the observed decline in point prevalence and new case detection rates, these changes were not statistically significant. …”

RV PV loop eccentricity during CPR. by Woo Jin Jung (3279570)

F05 demonstrates additive anti-tumor effects in combination with mAb therapy and reprograms M2 macrophages towards a phagocytotic phenotype. by Keifer G. Kurtz (21416918)

“…CD163 MFI is significantly decreased with F05 treatment (p = 0.0089, 55% decrease), but not 1H9 (p = 0.0828, 31% decrease) when compared to RITUX.…”

Histological appearance of NT2 CisR xenograft tumors without (A) and with (B) DNase treatment, and quantification of intratumoral microvascular density (C). by Mego Michal (22783828)

Expression of ‘muscle’ genes in the tendon during early postnatal development. by Heather L. Dingwall (14573796)

Identification of VHL as a novel E3 ubiquitin ligase for Vpx. by Kei Miyakawa (255697)

“…Data are presented as mean ± standard deviation (SD) (n = 2). Statistical significance was evaluated using a two-tailed unpaired <i>t</i>-test. …”

Uptake of the intervention (N = 49). by Stanley Carries (21172287)

“…There was a 1.32 unit (<i>p</i> = 0.085) decrease in depressive symptoms and a reduction in caregiver burden (β = -1.28, <i>p</i> = 0.020) in the intervention arm. …”

Baseline characteristics of sample by trial arm. by Stanley Carries (21172287)

“…There was a 1.32 unit (<i>p</i> = 0.085) decrease in depressive symptoms and a reduction in caregiver burden (β = -1.28, <i>p</i> = 0.020) in the intervention arm. …”

CweL trial design. by Stanley Carries (21172287)

“…There was a 1.32 unit (<i>p</i> = 0.085) decrease in depressive symptoms and a reduction in caregiver burden (β = -1.28, <i>p</i> = 0.020) in the intervention arm. …”

Participant Flow. by Stanley Carries (21172287)

“…There was a 1.32 unit (<i>p</i> = 0.085) decrease in depressive symptoms and a reduction in caregiver burden (β = -1.28, <i>p</i> = 0.020) in the intervention arm. …”

Economic cost composition by arm and outcomes. by Stanley Carries (21172287)

“…There was a 1.32 unit (<i>p</i> = 0.085) decrease in depressive symptoms and a reduction in caregiver burden (β = -1.28, <i>p</i> = 0.020) in the intervention arm. …”